Association between Dyslipidaemia and Cognitive Impairment: A Meta-Analysis of Cohort and Case-Control Studies

• Published in: Journal of integrative neuroscience Vol. 23; no. 2; p. 40
• Main Authors: Zhao, Yue, Zhang, Hongxia, Cheng, Jie, Zou, Yuting, Zhang, Daiying, Duan, Xiaoxia
• Format: Journal Article
• Language: English
• Published: Singapore IMR Press 19-02-2024
• Subjects: cognitive impairment; hyperlipidaemia; low-density lipoprotein cholesterol; meta-analysis; total cholesterol; triglyceride; triglyceride; meta-analysis; cognitive impairment; hyperlipidaemia; total cholesterol; low-density lipoprotein cholesterol
• ISSN: 0219-6352
• DOI: 10.31083/j.jin2302040

This study explored the specific relationship between different lipid indicators and cognitive impairment and aimed to provide a reference for implementing targeted lipid regulation measures to prevent and alleviate cognitive impairment.
We searched three databases (PubMed, Embase, and Web of Science) for literature related to hyperlipidaemia, lipid levels, and cognitive impairment, and used the Newcastle-Ottawa Scale to evaluate the quality of the identified literature. A meta-analysis was performed using RevMan 5.4, and the combined effect size ratio using a random-effects model (odds ratio [OR] and 95% confidence interval [CI]) was used to evaluate the association between dyslipidaemia and cognitive impairment.
Among initially identified 2247 papers, we ultimately included 18 studies involving a total of 758,074 patients. The results of the meta-analysis revealed that patients with hyperlipidaemia had a 1.23-fold higher risk of cognitive impairment than those with normal lipid levels (OR = 1.23, 95% CI: 1.04-1.47,
= 0.02). Further subgroup analysis showed that elevated total cholesterol (TC) levels increased the risk of cognitive impairment by 1.59-fold (OR = 1.59, 95% CI: 1.27-2.01,
< 0.0001) and were more significant in older or male patients. Moreover, elevated triglyceride levels were inversely correlated with cognitive disorders, whereas elevated low-density lipoprotein cholesterol levels were unrelated to cognitive impairment risk.
Dyslipidaemia was strongly associated with cognitive impairment, and elevated TC levels were a risk factor for cognitive impairment. Furthermore, the damaging effects of elevated TC levels on cognition were more pronounced in older and male populations.